David Ritchie

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity

Alexander J. Davenport, Ryan Cross, Katherine A. Watson et al. · Proceedings of the National Academy of Sciences · 2018 · 357 citations · Full text

Life Sciences, Immunology, Oncology +15

Late Ebola virus relapse causing meningoencephalitis: a case report

Michael Jacobs, Alison Rodger, David Bell et al. · The Lancet · 2016 · 356 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy

Charlotte Hughes, Amit Khot, Christopher McCormack et al. · Blood · 2014 · 225 citations

Medicine, Clinical Sciences, Oncology +4